Limited protection of GSK's malaria vaccine dwindles in 7 years
June 29, 2016 at 17:00 PM EDT
LONDON, June 29 (Reuters) - The world's first malaria vaccine, developed by GlaxoSmithKline, provides some protection after three doses but its effect dwindles to almost nothing after seven years, scientists said on Wednesday.